-
Prime Medicine's (PRME) "Outperform" Rating Reiterated at Wedbush
来源: Buzz FX / 19 3月 2025 22:21:17 America/New_York
Prime Medicine's (PRME) "Outperform" Rating Reiterated at Wedbush Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Prime Medicine ( NYSE:PRME - Get Free Report ) 's stock had its "outperform" rating reiterated
Read more...